原发性肝癌与Survivin及HGF的关系研究进展
被引量:1
出处
《右江民族医学院学报》
2005年第4期554-555,共2页
Journal of Youjiang Medical University for Nationalities
基金
广西科技厅自然基金资助项目(桂科0447109)
广西卫生厅科研课题(12004034)
参考文献19
-
1Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7 [J]. Biochemistry,2001,40:1117-1123.
-
2Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin [J]. Nature,1998,396:580-584.
-
3Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy [J]. Trends Mol Med,2001,7:542-547.
-
4Ito T, Shiraki K, Sugimoto K, et al. Survivin promotes cell proliferation in human hepatocellular carcinoma [J]. Hepatology,2000,31(5):1080-1085.
-
5Sohn J, Khaoustov VI, Xie Q, et al. The effect of ursodeoxycholic acid on the survivin in thapsigargin-induced apoptosis [J]. Cancer Lett,2003,191(1):83-92.
-
6Marusawa H, Matsuzawa S, Welsh K, et al. HBXIP functions as a cofactor of survivin in apoptosis suppression [J]. EMBO J,2003,22(11):2729-2740.
-
7Shigeno M, Nakao K, Ichikawa T, et al. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation [J]. Oncogene,2003,22(11):1653-1662.
-
8Ikeguchi M, Ueda T, Sakatani T, et al. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma [J]. Diagn Mol Pathol,2002,11(1):33-40.
-
9Ikeguchi M, Hirooka Y, Kaibara N. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma [J]. Cancer,2002,95(9):1938-1945.
-
10何勇,窦科峰,周峻.肝细胞生长因子表达载体的构建及在人肝细胞中的表达[J].中华肝脏病杂志,2002,10(2):119-119. 被引量:1
二级参考文献12
-
1Qian Xie Kang-Da Liu Mei-Yu Hu Kang Zhou Experimental Research Center of Zhongshan Hospital,Fudan University,Shanghai,200032,China.SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(6):816-820. 被引量:24
-
2丛文铭,吴孟超,陈汉,张秀忠,董秀芬.DNA含量分析对复发性肝细胞癌克隆来源及其临床意义的初步研究[J].临床肝胆病杂志,1993,9(1):3-5. 被引量:26
-
3[1]Tsubouchi H, Niitani Y, Hirono S et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-lined immunosorbent assay. Hepatology,1991, 13(1):1
-
4[2]Ramadori G, Neubauer K, Odenthal M et al. The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-beta.. Biochem Biophys Res Commun,1992,183(2):739
-
5[3]Schirmacher P, Geerts A, Pietrangeio A et al. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but nor myofibroblast-like cells derived from fat-storing cells. Hepatology,1992,15(1):5
-
6[4]Kinoshita T, Hirao S, Matsumoto K et al. Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem Biophys Res Commun,1991,177(1):330
-
7[5]Tomiya T, Tani M, Yamada S et al. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology,1992,103(5):1 621
-
8[6]Okuda K, Tanaka M, Nakayama T et al. Clinicopathologic comparison between resected hepatocellular carcinomas and recurrent tumors. Int Hepatology Commun,1993,1(1):65
-
9[8]Shiota G, Rhoads DB, Wang TC et al. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA,1992,89(1):373
-
10Jahroudi N, Joel S. The role of endothelial cells in tumor invasion and metastasis [J]. J NeuroOncol, 1995, 23: 99-108.
共引文献4
-
1王冰,姬长友.肝细胞生长因子及其受体c-Met蛋白在喉部肿瘤的研究进展[J].临床耳鼻咽喉科杂志,2006,20(9):426-429. 被引量:1
-
2李立祥,熊奇如.肝癌术后复发转移的相关影响因素研究进展[J].现代肿瘤医学,2007,15(12):1869-1872. 被引量:3
-
3罗放,王济明,吴晓健,乐艾文.原发性肝癌患者手术前后血浆HGF水平变化及其临床意义[J].激光杂志,2008,29(1):90-91. 被引量:1
-
4蔡云峰,甄作均,陈焕伟,苏树英.肝癌术后肝再生状态与肝癌复发关系的初步研究[J].中国普通外科杂志,2008,17(7):692-696. 被引量:8
同被引文献21
-
1刘喜泰,韩絮琳,屠振兴,秦一中,崔正权.原发性肝癌与乙型、丙型肝炎病毒感染的关系[J].第二军医大学学报,1994,15(1):11-14. 被引量:6
-
2杨建民,刘为纹.丙型肝炎病毒感染与原发性肝癌关系的研究[J].第三军医大学学报,1994,16(1):55-55. 被引量:6
-
3钱炳圭,鲁猛厚,汪玲,龚环宇,卢文能.原发性肝癌与乙型肝炎病毒感染[J].湖南医科大学学报,1994,19(4):357-358. 被引量:3
-
4陈思红,周筱梅,李岱宗,钱莲芳,顾健人.人肝癌组织IGF-Ⅱ cDNA变异体的克隆和顺序分析[J].科学通报,1994,39(7):664-666. 被引量:4
-
5黄根牙,马兴刚,王昌成.重度饮酒与HBV相关肝癌危险性的关系[J].肿瘤防治杂志,2005,12(6):405-408. 被引量:5
-
6沈玲,赵伟,舒伟平,方之勋.青年肝炎、肝硬化患者中肝癌早期诊断的相关因素[J].江苏医药,2005,31(6):416-418. 被引量:9
-
7梁桂华,田泽允.农村成人HBV感染状况及与原发性肝癌的相关性[J].中国公共卫生管理,2005,21(3):218-219. 被引量:4
-
8林述龙,陈硕,王晓华.原发性肝癌128例临床分析[J].中国现代医学杂志,2005,15(9):1426-1428. 被引量:6
-
9肖开银,黎乐群,彭民浩,杨定华,梁水庭,覃晓,陈希刚,郭雅,覃忠,彭涛,陈滨,苏智雄,尚丽明.家族聚集性肝癌101例家族史和临床分析[J].广西医科大学学报,2005,22(2):224-226. 被引量:16
-
10王冬菊,张平.原发性肝癌66例临床资料分析[J].中国社区医师(医学专业),2005,7(9):22-23. 被引量:1
二级引证文献3
-
1陈嘉波,杨体泉,陈超,罗意革,唐咸明,董淳强.儿童肝细胞肝癌与肝母细胞瘤的临床特点及预后[J].实用儿科临床杂志,2007,22(15):1147-1148. 被引量:8
-
2刘玉萍,王林,戴敏.成都市区健康体检人群乙型肝炎病毒血清学标志检测结果分析[J].职业卫生与病伤,2008,23(5):300-302.
-
3张伟东,周小明,候春美,龚振.肝动脉节段性化疗栓塞治疗原发性肝癌36例临床分析[J].中国医药导报,2012,9(4):67-68.
-
1秦克旺,黄顺生.远端胃癌根治性切除术后复发再次手术的临床分析[J].江西医学院学报,2002,42(5):75-75.
-
2巩书磊,张林,张曙光,李文雅,刘相利,钟欣文.胸部孤立性纤维瘤的临床诊治[J].中华胸心血管外科杂志,2012,28(11):690-691. 被引量:2
-
3刘续宝.胰腺癌根治性手术的再认识和展望[J].中国普外基础与临床杂志,2006,13(5):500-501. 被引量:7
-
4黄景利,薄爱华.乳腺癌中三种耐药蛋白(BCRP,LRP和TS)的研究进展[J].医学综述,2009,15(21):3216-3218. 被引量:1
-
5张峻霄.卵巢交界性肿瘤的临床处理[J].国外医学(妇产科学分册),2001,28(4):225-228. 被引量:3
-
6张雷,张才全.整合素与肿瘤[J].重庆医学,2003,32(9):1261-1263. 被引量:6
-
7张剑林,钱叶本.复发性肝癌的治疗选择[J].中华临床医师杂志(电子版),2015,9(18):5-7. 被引量:3
-
8赵平,田艳涛.如何提高胰腺癌R0切除率[J].肝胆外科杂志,2013,21(3):165-167.
-
9薛晓英.如何选择癌症治疗方案[J].医药前沿,2014(14):59-59.
-
10袁霞.宫颈癌化疗新进展[J].浙江临床医学,2014,16(4):655-657. 被引量:2